NCT07114874 - NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia | Biotech Hunter

Enrollment

800

Participants

Timeline

Start Date

July 11, 2025

Primary Completion Date

December 31, 2031

Study Completion Date

December 31, 2031

Conditions

Schizophrenia

Interventions

DRUG

NBI-1117568

NBI-1117568 will be administered per schedule specified in the arm description.

Trial Locations (24)

10314

RECRUITING

Neurocrine Clincial Site, Staten Island

10461

RECRUITING

Neurocrine Clinical Sites, The Bronx

20877

RECRUITING

Neurocrine Clinical Site, Gaithersburg

30030

RECRUITING

Neurocrine Clinical Site, Decatur

30071

RECRUITING

Neurocrine Clinical Sites, Peachtree Corners

30328

RECRUITING

Neurocrine Clinical Site, Atlanta

30331

RECRUITING

Neurocrine Clinical Site, Atlanta

33016

RECRUITING

Neurocrine Clinical Site, Miami Lakes

33024

RECRUITING

Neurocrine Clinical Site, Hollywood

44720

RECRUITING

Neurocrine Clinical Sites, North Canton

60640

RECRUITING

Neurocrine Clinical Site, Chicago

63141

RECRUITING

Neurocrine Clinical Site, St Louis

72211

RECRUITING

Neurocrine Clinical Site, Little Rock

78754

RECRUITING

Neurocrine Clinical Site, Austin

84058

RECRUITING

Neurocrine Clinical Sites, Orem

90230

RECRUITING

Neurocrine Clinical Site, Culver City

90504

RECRUITING

Neurocrine Clinical Site, Torrance

90660

RECRUITING

Neurocrine Clinical Site, Pico Rivera

91403

RECRUITING

Neurocrine Clinical Site, Sherman

92123

RECRUITING

Neurocrine Clinical Site, San Diego

92506

RECRUITING

Neurocrine Clinical Site, Riverside

92845

RECRUITING

Neurocrine Clinical Site, Garden Grove

02472

RECRUITING

Neurocrine Clinical Site, Watertown

08053

RECRUITING

Neurocrine Clinical Site, Marlton